Evidence map›Paper›PMID 18680106›Full record

ArticleMolecular carcinogenesis2009

Enhancement of p53 expression in keratinocytes by the bioflavonoid apigenin is associated with RNA-binding protein HuR.

Xin Tong, Jill C Pelling

Open access · greenAbstract read
In one paragraph

Article in Molecular carcinogenesis, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.Anti-cancer agents in medicinal chemistry · 2013
    Review
  8. Article
  9. Article
  10. Article
  11. Regulation of tumor suppressor p53 at the RNA level.Journal of molecular medicine (Berlin, Germany) · 2010
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Xin TongDepartment of Pathology and the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Jill C Pelling
Northwestern University · US

Funding

Inhibition of UVB-induced COX-2 expression by apigeninR01CA104768 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PELLING, JILL C. · 2004 to 2008
$1.4M
MOLECULAR MECHANISM OF CHEMOPREVENTION BY APIGENINR01CA072987 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI PELLING, JILL C. · 1996 to 2004
$1.1M
NCI NIH HHS CA072987NCI NIH HHS CA104768NCI NIH HHS R01 CA072987NCI NIH HHS R01 CA104768
6 · The paper itself

Abstract

We have reported previously that apigenin, a naturally occurring nonmutagenic flavonoid, increased wild-type p53 protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization. Here we further demonstrated that the increase in p53 protein level induced by apigenin treatment of 308 keratinoyctes was not the result of enhanced transcription, mRNA stabilization or cytoplasmic export of p53 mRNA. Instead, biosynthetic labeling showed that apigenin increased nascent p53 protein synthesis by enhancing p53 translation. The AU-rich element (ARE) within the 3'-untranslated region (UTR) of p53 mRNA was found to be responsible for apigenin's ability to increase p53 translation, as demonstrated in studies wherein the 3'-UTR of p53 mRNA containing the ARE was fused downstream of a luciferase reporter gene. Furthermore, apigenin treatment increased the level of association of the RNA binding protein HuR with endogenous p53 mRNA. Apigenin treatment also augmented HuR translocation into the cytoplasm. Overexpression of HuR enhanced apigenin-induced p53 protein expression in 308 keratinocytes, whereas siRNA-mediated HuR reduction suppressed apigenin-induced p53 protein expression and de novo translation of p53. Moreover, apigenin treatment of cells induced p16 protein expression, which in turn was correlated with cytoplasmic localization of HuR induced by apigenin. Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which apigenin induces p53 protein expression is enhancement of translation through the RNA binding protein HuR.

Indexed as

AnimalsAntigens, SurfaceApigeninBase SequenceBlotting, WesternCell LineDNA PrimersELAV-Like Protein 1ELAV ProteinsFluorescent Antibody TechniqueImmunoprecipitationKeratinocytesMiceMice, Inbred BALB CPolymerase Chain ReactionProtein BiosynthesisAntigens, SurfaceApigeninDNA PrimersELAVL1 protein, humanELAV-Like Protein 1ELAV ProteinsRNA-Binding ProteinsRNA, MessengerTumor Suppressor Protein p53

Identifiers

PMID18680106
PMCPMC2631086
OpenAlexW1990334559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.